CCIA
ABBV icon

Cherry Creek Investment Advisors’s AbbVie ABBV Stock Holding History

Cherry Creek Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.94M Buy
27,564
+309
+1% +$66.5K 2.73% 12
2026
Q1 		$5.93M Sell
27,255
-982
-3% -$218K 2.58% 12
2025
Q4 		$6.45M Sell
28,237
-24
-0.1% -$5.47K 2.76% 11
2025
Q3 		$6.54M Buy
28,261
+28
+0.1% +$5.7K 2.83% 11
2025
Q2 		$5.24M Buy
28,233
+112
+0.4% +$20.8K 2.46% 12
2025
Q1 		$5.89M Buy
28,121
+87
+0.3% +$16.9K 3.07% 9
2024
Q4 		$4.98M Buy
28,034
+237
+0.9% +$43.6K 2.45% 13
2024
Q3 		$5.49M Buy
27,797
+18
+0.1% +$3.36K 2.84% 10
2024
Q2 		$4.76M Buy
27,779
+293
+1% +$48.5K 2.49% 12
2024
Q1 		$5.01M Sell
27,486
-1,771
-6% -$305K 2.71% 11
2023
Q4 		$4.53M Buy
29,257
+329
+1% +$48K 2.77% 11
2023
Q3 		$4.31M Buy
28,928
+260
+0.9% +$38.2K 2.93% 12
2023
Q2 		$3.86M Buy
28,668
+315
+1% +$46.2K 2.6% 12
2023
Q1 		$4.52M Sell
28,353
-11
-0% -$1.68K 3.31% 10
2022
Q4 		$4.58M Buy
28,364
+268
+1% +$41.1K 3.56% 10
2022
Q3 		$3.77M Buy
28,096
+486
+2% +$69.7K 3.13% 10
2022
Q2 		$4.23M Buy
27,610
+60
+0.2% +$9.17K 3.41% 10
2022
Q1 		$4.47M Sell
27,550
-16
-0.1% -$2.32K 2.94% 10
2021
Q4 		$3.73M Buy
27,566
+728
+3% +$86K 2.32% 12
2021
Q3 		$2.9M Buy
26,838
+1,215
+5% +$139K 1.93% 14
2021
Q2 		$2.89M Buy
+25,623
New +$2.89M 1.9% 15

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cherry Creek Investment Advisors's ABBV Position: Q2 2026 in Review

Cherry Creek Investment Advisors increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $66.5K and bringing the position to 27,564 shares worth $6.94M. The position accounts for 2.73% of the portfolio, ranked #12.

Cherry Creek Investment Advisors first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cherry Creek Investment Advisors held 27,564 shares of AbbVie worth $6.94M as of Q2 2026.
  • Cherry Creek Investment Advisors bought 309 AbbVie shares in Q2 2026, an estimated $66.5K.
  • AbbVie made up 2.73% of Cherry Creek Investment Advisors's portfolio in Q2 2026, its #12 holding.
  • Cherry Creek Investment Advisors first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cherry Creek Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.